Frataxin deficiency in pancreatic islets causes diabetes due to loss of beta cell mass

M Ristow, Hindrik Mulder, D Pomplun, T Schulz, K Muller-Schmehl, A Krause, Malin Fex, H Puccio, J Muller, F Isken, J Spranger, D Muller-Wieland, MA Magnuson, M Mohlig, M Koenig, AFH Pfeiffer

Research output: Contribution to journalArticlepeer-review


Diabetes is caused by an absolute (type 1) or relative (type 2) deficiency of insulin-producing beta cells. We have disrupted expression of the mitochondrial protein frataxin selectively in pancreatic beta cells. Mice were born healthy but subsequently developed impaired glucose tolerance progressing to overt diabetes mellitus. These observations were explained by impairment of insulin secretion due to a loss of beta cell mass in knockout animals. This phenotype was preceded by elevated levels of reactive oxygen species in knockout islets, an increased frequency of apoptosis, and a decreased number of proliferating beta cells. Hence, disruption of the frataxin gene in pancreatic beta cells causes diabetes following cellular growth arrest and apoptosis, paralleled by an increase in reactive oxygen species in islets. These observations might provide insight into the deterioration of beta cell function observed in different subtypes of diabetes in humans.
Original languageEnglish
Pages (from-to)527-534
JournalJournal of Clinical Investigation
Issue number4
Publication statusPublished - 2003

Subject classification (UKÄ)

  • Endocrinology and Diabetes


Dive into the research topics of 'Frataxin deficiency in pancreatic islets causes diabetes due to loss of beta cell mass'. Together they form a unique fingerprint.

Cite this